Yin Hongze, Wang Yue, Liu Na, Zhong Songyi, Li Long, Zhang Quan, Liu Zeyang, Yue Tao
School of Mechatronic Engineering and Automation, Shanghai University, Shanghai 200444, China.
School of Future Technology, Shanghai University, Shanghai, China.
Cyborg Bionic Syst. 2024 Apr 25;5:0107. doi: 10.34133/cbsystems.0107. eCollection 2024.
Microvasculature plays a crucial role in human physiology and is closely related to various human diseases. Building in vitro vascular networks is essential for studying vascular tissue behavior with repeatable morphology and signaling conditions. Engineered 3D microvascular network models, developed through advanced microfluidic-based techniques, provide accurate and reproducible platforms for studying the microvasculature in vitro, an essential component for designing organ-on-chips to achieve greater biological relevance. By optimizing the microstructure of microfluidic devices to closely mimic the in vivo microenvironment, organ-specific models with healthy and pathological microvascular tissues can be created. This review summarizes recent advancements in in vitro strategies for constructing microvascular tissue and microfluidic devices. It discusses the static vascularization chips' classification, structural characteristics, and the various techniques used to build them: growing blood vessels on chips can be either static or dynamic, and in vitro blood vessels can be grown in microchannels, elastic membranes, and hydrogels. Finally, the paper discusses the application scenarios and key technical issues of existing vascularization chips. It also explores the potential for a novel organoid chip vascularization approach that combines organoids and organ chips to generate better vascularization chips.
微血管系统在人体生理学中起着至关重要的作用,并且与多种人类疾病密切相关。构建体外血管网络对于研究具有可重复形态和信号条件的血管组织行为至关重要。通过先进的基于微流控的技术开发的工程化三维微血管网络模型,为体外研究微血管系统提供了准确且可重复的平台,这是设计器官芯片以实现更高生物学相关性的重要组成部分。通过优化微流控装置的微观结构以紧密模拟体内微环境,可以创建具有健康和病理微血管组织的器官特异性模型。本综述总结了构建微血管组织和微流控装置的体外策略的最新进展。它讨论了静态血管化芯片的分类、结构特征以及用于构建它们的各种技术:芯片上的血管生长可以是静态的或动态的,体外血管可以在微通道、弹性膜和水凝胶中生长。最后,本文讨论了现有血管化芯片的应用场景和关键技术问题。它还探讨了一种将类器官和器官芯片相结合以生成更好的血管化芯片的新型类器官芯片血管化方法的潜力。